If you made any changes in Pure these will be visible here soon.

Personal profile


To process information the brain is constantly changing the strength of the individual contacts (synapses) between nerve cells. Strict control of synaptic plasticity is important, as dysregulation is often associated with neurological disorders.

My lab studies the mechanisms that support synaptic plasticity and their dysfunction in disorders such as Alzheimer’s, epilepsy, schizophrenia and autism to provide novel treatment options and therapeutic targets.

We study:

Presynaptic mechanisms of synaptic plasticity

We investigate synaptic transmission mechanisms by studying the function of key proteins of the synaptic vesicle release machinery (Stxbp1, SV2, o.a.) in wildtype and disease model systems (mouse and human IPSC-derived neurons). One important goal is to design rational therapeutic strategies. We have identified several kinase pathways (PKC, ERK, CDK5, PNAS 2006, Neuron 2007, JCB 2014, EMBOJ 2016) and other modifiers (Fbxo41, Sci Rep 2019, iScience 2022) that control synaptic transmission. These pathways are excellent drug targets for treatment of brain disorders. In addition, thanks to our expert knowledge on synaptic proteins we collaborate with several biotech/pharma companies to develop novel anti-epileptic therapies, cognition enhancers, gene therapeutics for rare brain disorders, and therapeutic delivery options. 

Secretory vesicle dynamics and release

Neuropeptides are neuromodulatory molecules that control vital biological processes. Dysregulation of neuropeptide secretion is associated with cognitive disorders, obesity and diabetes. We study neuropeptide release mechanisms and the effect of secreted neuropeptides on synaptic transmission in several disease models. Using novel optical assays, we have identified the major proteins controlling neuropeptide vesicle release (JCB 2012, eLife 2015, JCS 2017, Neuron 2019). We use this knowledge to study neuropeptide signaling in brain disorders such as Prader Willi Syndrome and Obesities. In addition, we exploit our in-depth knowledge on release principles to study secretion and uptake of extracellular vesicles (EVs or exosomes). We study the potential of these EVs as therapeutic delivery vehicles for brain disorders.


I coordinate the Fundamental Neurocience track in the second year of the Research Master Neuroscience.

I coordinate the Minor Biomolecular and Neurosciences track Neuroscience, and the Master courses Live Cell Imaging and Developmental Neuroscience.

I am a member of the Master of Neurocience education committee and the ONWAR PhD teaching committee 

Ancillary activities

No ancillary activities

Ancillary activities are updated daily

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Academic qualification

Neuroscience, PhD, The role of Munc18-1 in regulated secretion, Utrecht University

Award Date: 3 Jun 2002

User created Keywords

  • synapse
  • brain function
  • secretory vesicles
  • synaptic plasticity
  • neuropeptides
  • neuronal cilia


Dive into the research topics where Ruud Toonen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or